These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 19437491
21. Purification of full-length human pregnane and xenobiotic receptor: polyclonal antibody preparation for immunological characterization. Saradhi M, Krishna B, Mukhopadhyay G, Tyagi RK. Cell Res; 2005 Oct; 15(10):785-95. PubMed ID: 16246268 [Abstract] [Full Text] [Related]
22. Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Gupta D, Venkatesh M, Wang H, Kim S, Sinz M, Goldberg GL, Whitney K, Longley C, Mani S. Clin Cancer Res; 2008 Sep 01; 14(17):5332-40. PubMed ID: 18765524 [Abstract] [Full Text] [Related]
23. Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice. Choi S, Neequaye P, French SW, Gonzalez FJ, Gyamfi MA. J Biol Chem; 2018 Jan 05; 293(1):1-17. PubMed ID: 29123032 [Abstract] [Full Text] [Related]
24. Effects of fatty acids on hepatic gene expression. Jump DB, Ren B, Clarke S, Thelen A. Prostaglandins Leukot Essent Fatty Acids; 1995 Jan 05; 52(2-3):107-11. PubMed ID: 7784444 [Abstract] [Full Text] [Related]
25. Rat hepatic mRNA-S14 and lipogenic enzymes during weaning: role of S14 in lipogenesis. Perez-Castillo A, Schwartz HL, Oppenheimer JH. Am J Physiol; 1987 Nov 05; 253(5 Pt 1):E536-42. PubMed ID: 3688223 [Abstract] [Full Text] [Related]
26. SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. Li L, Li H, Garzel B, Yang H, Sueyoshi T, Li Q, Shu Y, Zhang J, Hu B, Heyward S, Moeller T, Xie W, Negishi M, Wang H. Mol Pharmacol; 2015 Apr 05; 87(4):674-82. PubMed ID: 25628225 [Abstract] [Full Text] [Related]
27. Hepatic expression of the SPOT 14 (S14) paralog S14-related (Mid1 interacting protein) is regulated by dietary carbohydrate. Tsatsos NG, Augustin LB, Anderson GW, Towle HC, Mariash CN. Endocrinology; 2008 Oct 05; 149(10):5155-61. PubMed ID: 18556348 [Abstract] [Full Text] [Related]
28. Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats. Maeda T, Oyabu M, Yotsumoto T, Higashi R, Nagata K, Yamazoe Y, Tamai I. Drug Metab Dispos; 2007 Sep 05; 35(9):1580-6. PubMed ID: 17553914 [Abstract] [Full Text] [Related]
29. "Spot 14" protein: a metabolic integrator in normal and neoplastic cells. Cunningham BA, Moncur JT, Huntington JT, Kinlaw WB. Thyroid; 1998 Sep 05; 8(9):815-25. PubMed ID: 9777755 [Abstract] [Full Text] [Related]
30. Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Moreau A, Vilarem MJ, Maurel P, Pascussi JM. Mol Pharm; 2008 Sep 05; 5(1):35-41. PubMed ID: 18159929 [Abstract] [Full Text] [Related]
31. Role of nuclear pregnane X receptor in Cu-induced lipid metabolism and xenobiotic responses in largemouth bass (Micropterus salmoides). Li H, Gong W, Wang G, Yu E, Tian J, Xia Y, Li Z, Zhang K, Xie J. Front Endocrinol (Lausanne); 2022 Sep 05; 13():950985. PubMed ID: 35966089 [Abstract] [Full Text] [Related]
32. Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability. Wang W, Prosise WW, Chen J, Taremi SS, Le HV, Madison V, Cui X, Thomas A, Cheng KC, Lesburg CA. Protein Eng Des Sel; 2008 Jul 05; 21(7):425-33. PubMed ID: 18456871 [Abstract] [Full Text] [Related]
33. Compared analysis of the regulatory systems controlling lipogenesis in hepatocytes of mice and in maturing oilseeds of Arabidopsis. Baud S, Lepiniec L. C R Biol; 2008 Oct 05; 331(10):737-45. PubMed ID: 18926487 [Abstract] [Full Text] [Related]
34. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. Cariou B. Diabetes Metab; 2008 Dec 05; 34(6 Pt 2):685-91. PubMed ID: 19195631 [Abstract] [Full Text] [Related]
36. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Köhle C, Bock KW. Biochem Pharmacol; 2009 Feb 15; 77(4):689-99. PubMed ID: 18606396 [Abstract] [Full Text] [Related]
37. Computational discovery of novel low micromolar human pregnane X receptor antagonists. Ekins S, Kholodovych V, Ai N, Sinz M, Gal J, Gera L, Welsh WJ, Bachmann K, Mani S. Mol Pharmacol; 2008 Sep 15; 74(3):662-72. PubMed ID: 18579710 [Abstract] [Full Text] [Related]
38. Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. Gwag T, Meng Z, Sui Y, Helsley RN, Park SH, Wang S, Greenberg RN, Zhou C. J Hepatol; 2019 May 15; 70(5):930-940. PubMed ID: 30677459 [Abstract] [Full Text] [Related]
39. Hepatic overexpression of dominant negative Mlx improves metabolic profile in diabetes-prone C57BL/6J mice. Iizuka K, Takeda J, Horikawa Y. Biochem Biophys Res Commun; 2009 Feb 06; 379(2):499-504. PubMed ID: 19121288 [Abstract] [Full Text] [Related]
40. In silico prediction of pregnane X receptor activators by machine learning approaches. Ung CY, Li H, Yap CW, Chen YZ. Mol Pharmacol; 2007 Jan 06; 71(1):158-68. PubMed ID: 17003167 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]